DAY 2
Wednesday, 23 September 2026
08h00
Welcome Coffee
08h40
Strengthening QA/QC Systems to Support Compliance, Robustness and Performance
- E-Lounge Auditorium
Chairman
10h00
How to avoid a Complete Response Letter (CRL): Implications for Product Access
Natalia PRIPUZOVA
CEO, Founder & Regulatory Affairs CMC Consulting
NPDK Bioconsulting, USA
10h00
Designing and implementing a useful quality management system for startups or research providers in the healthcare industries
Sophie MICHEL
Consultant
Sophie Michel Consulting, France
Marc DUBOURDEAU
Chairman
AMBIOTIS, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
10h00
Is Your Product Clear? Residual Deviron® Quantification in Release Testing
Sandra de BARROS
Senior Technical Specialist
Merck BioReliance, France
10h00
Regulatory-Driven Analytical Strategies for Safety-Related Critical Quality Attributes in Bioproduction
Mourad FERHAT
Regional Manager Western and Southern Europe
ACROBiosystems, France
Facility Design and Automation: Smart Manufacturing to Support the Paradigm Shift
- H-Experience Auditorium
Chairman
10h00
AI-Enabled Regulatory Submissions
Sabine LECLERCQ
Founder
Leclercq Biopharma Consulting, Belgium
10h00
Key successes and learning when moving from PD to manufacturing with smart digital technology
Guilherme RAMOS
Data Scientist
DataHow, Switzerland
10h00
Operational AI in CMC: Document Intelligence, Regulatory Insight & Process Risk Reduction
Olivier FAVRE-BULLE
Founder, CEO & Consultant in Drug Development
3Biotech, France
10h00
An Innovative Solution for Disinfecting Equipment Airlocks, or How to Manage Contamination Risk with a Single Click
Charlotte GOURRAUD
Scientific and Quality Director
Devea Environnement, France
10h00
End-to-End Automation of QC Laboratories: Opportunities and Obstacles
Sébastien CONILLEAU
Senior Strategic Consultant
Wega, France
10h40
Coffee Break at the Exhibition Hall - B2B Meetings
11h10
Workshops
Chairman
12h10
Lunch Break at the Exhibition Hall - B2B Meetings
14h00
Regulatory Perspectives on Bioprocessing
- E-Lounge Auditorium
Chairman
10h00
The Great Regulatory Convergence: Strategic Navigation of the Evolving Global Biosimilar Landscape and the Implementation of ICH M18
Akansh DIXIT
Director & Global Regulatory Affairs Lead
Fresenius Kabi, Switzerland
10h00
Regulatory Strategy in Biotech: Accelerating Development, Managing Changes and Preparing for Market Access
Frédérique VIEVILLE
CEO
5QBD-Biotech, France
Camille DESPREAUX
Regulatory Affairs & Pharmacovigilance Pharmacist
Biotrial, France
Houda BELTAIEF
Associate Director CMC Regulatory Affairs
Merck Group, France
Breakthrough Innovations in Bioprocessing - Part II
- H-Experience Auditorium
Chairman
10h00
Ink-jet Bioprinting of hydrogel microbeads for large-scale cultivation of Human MSCs
Alejandro AVILAN GARZON
Postdoctoral Researcher
3d.FAB – Université Claude Bernard Lyon 1, France
10h00
MyrmiCell: from biology to mathematics, algorithmic innovation for bioprocesses
Maxime BÉRANGER
CEO
MB3 Biostatistics, France
10h00
Viro-ID -Enhancing Virus Analysis through Nanopore Technology
Léa CHAZOT-FRANGUIADAKIS
Research Engineer
Viro-ID & ENS Lyon, France
10h00
From Formulation to Bioproduction: Why Next-Generation Therapies Require Next-Generation Encapsulation Technologies
Fabien BALME
CEO
Biotech One, France
10h00
Challenges of biological product stabilisation : the contribution of dynamic lyophilisation
Marie-Hélène GRAMATIKOFF
CEO
Lyophitech, France
15h00
Supply Chain Sustainability: Challenges and Innovative Solutions
- E-Lounge Auditorium
Chairman
10h00
Shifting from sustainability commitment to innovative concrete actions: the role of supply chain
Mathilde BARTHE
Marketing Development Manager
Saint-Gobain Bioprocess Solutions, France
Caroline CALMELS
Sustainability Market Manager
Saint-Gobain Bioprocess Solutions, France
10h00
Embedding Sustainability from R&D to Delivery in Bioprocess Technologies
Guy SOUBEYROUX
Senior Director - Sustainability
Cytiva, France
10h00
Addressing the PFAS Challenge in Pharma: Innovative Solutions for TFA Removal from Wastewater
Estelle CLERC
Founder and CEO
CellX Biosolutions, Switzerland
16h00
Closing Keynote Lecture
- E-Lounge Auditorium
Chairman
10h00
Title
Bjarke SKAANNING
Director
Kalundborg Symbiose, Denmark
17h00